Sunshine Biopharma SBFM
NASDAQ SBFM
$0.67 -0.02 (-2.90%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sunshine Biopharma (SBFM) Return on Sales [ROS] (2015 - 2026)

Updated

Sunshine Biopharma's Return on Sales [ROS] came in at -17.41% for Q2 2026, up 4.42 percentage points from -21.83% a year earlier but down 0.16 percentage points from the prior quarter.

Analysis

Sunshine Biopharma (SBFM) Return on Sales [ROS] (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Sunshine Biopharma reported Return on Sales [ROS] of -16.65%, up 1.22 percentage points year-over-year; for FY2025, it came in at -17.15%, down 0.49 percentage points from FY2024.

  • Return on Sales [ROS] carries a five-year change of +790.68 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Sales [ROS] was -16.67% in FY2024 (+3.20 pp), -19.86% in FY2023 (+601.47 pp), -621.33% in FY2022 (+446.90 pp) and -1068.24% in FY2021 (-260.40 pp).
  • The five-year range for quarterly Return on Sales [ROS] is -1293.58% (Q3 2022) to -11.54% (Q3 2025).
  • Year-over-year, Return on Sales [ROS] increased in four of the last eight quarters, with an average year-over-year change of -0.87 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q1 2022 (a gain of 2187.01 percentage points), and the weakest in Q3 2021 (a drop of 592.76 percentage points).
  • Business Quant data shows SBFM's Return on Sales [ROS] at -17.25% (Q1 2026), -20.87% (Q4 2025) and -11.54% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 28.21%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 37.86%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 32.97%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 20.57%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 34.95%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -133.21%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 28.37%
10 Sunshine Biopharma 942,073.56 -38.15 Mn 2.43 Mn -17.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.41%
Mar 31, 2026 -17.25%
Dec 31, 2025 -20.87%
Sep 30, 2025 -11.54%
Jun 30, 2025 -21.83%
Mar 31, 2025 -14.56%
Dec 31, 2024 -21.24%
Sep 30, 2024 -13.12%
Jun 30, 2024 -13.63%
Mar 31, 2024 -17.91%
Dec 31, 2023 -15.46%
Sep 30, 2023 -13.08%
Jun 30, 2023 -18.23%
Mar 31, 2023 -37.37%
Dec 31, 2022 -593.01%
Sep 30, 2022 -1,293.58%
Jun 30, 2022 -462.92%
Mar 31, 2022 -997.48%
Dec 31, 2021 -328.52%
Sep 30, 2021 -985.11%
API Access

Sunshine Biopharma Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SBFM&period=max&api_key=YOUR_API_KEY